Evolving Management Strategies for Treatment-Resistant Depression - Episode 12

Treatment-Resistant Depression: Financial Support for Esketamine Therapy

May 27, 2021
Steven P. Levine, MD

Angelos Halaris, MD, PhD, APA, ACNP, CINP

Lisa Harding, MD

Patricia Ares-Romero, MD, FASAM

Recommendations that can help clinicians navigate through the reimbursement process and best support patients who receive intranasal esketamine for treatment-resistant depression.